Shingles vaccine safety checked in pregnant women with immune issues
NCT ID NCT05811754
First seen Nov 12, 2025 · Last updated May 02, 2026 · Updated 22 times
Summary
This study looks at the safety of the shingles vaccine (HZ/su) in pregnant women aged 18-49 with weakened immune systems. It compares rates of major birth defects and other infant health problems between vaccinated and unvaccinated women. The goal is to gather real-world safety data to guide vaccine use during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Canton, Massachusetts, 02021, United States
Conditions
Explore the condition pages connected to this study.